Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3
Go back to Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 87.25 -1.99 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.24 | 52 Week High | $8.22 | |||
| Open | $89.09 | 52 Week Low | $3.07 | |||
| Day High | $90.61 | P/E | N/A | |||
| Day Low | $87.16 | EPS | $-1.30 | |||
| Volume | 1,099,830 | |||||
